Global Healthcare-associated Infectious Disease Diagnostics Market Growth (Status and Outlook) 2024-2031

Report ID: 1289593 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Healthcare-associated Infectious Disease Diagnostics Market Size 2017-2028
        2.1.2 Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
    2.2 Healthcare-associated Infectious Disease Diagnostics Segment by Type
        2.2.1 Urinary Tract Infections
        2.2.2 Surgical Site Infections
        2.2.3 Hospital-acquired Pneumonia
        2.2.4 BloodStream Infections
        2.2.5 Gastrointestinal Infections
    2.3 Healthcare-associated Infectious Disease Diagnostics Market Size by Type
        2.3.1 Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
        2.3.2 Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2022)
    2.4 Healthcare-associated Infectious Disease Diagnostics Segment by Application
        2.4.1 Hospitals
        2.4.2 Clinics
        2.4.3 ASCs
    2.5 Healthcare-associated Infectious Disease Diagnostics Market Size by Application
        2.5.1 Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
        2.5.2 Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2022)
3 Healthcare-associated Infectious Disease Diagnostics Market Size by Player
    3.1 Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Players
        3.1.1 Global Healthcare-associated Infectious Disease Diagnostics Revenue by Players (2020-2022)
        3.1.2 Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Players (2020-2022)
    3.2 Global Healthcare-associated Infectious Disease Diagnostics Key Players Head office and Products Offered
    3.3 Market Concentration Rate Analysis
        3.3.1 Competition Landscape Analysis
        3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.4 New Products and Potential Entrants
    3.5 Mergers & Acquisitions, Expansion
4 Healthcare-associated Infectious Disease Diagnostics by Regions
    4.1 Healthcare-associated Infectious Disease Diagnostics Market Size by Regions (2017-2022)
    4.2 Americas Healthcare-associated Infectious Disease Diagnostics Market Size Growth (2017-2022)
    4.3 APAC Healthcare-associated Infectious Disease Diagnostics Market Size Growth (2017-2022)
    4.4 Europe Healthcare-associated Infectious Disease Diagnostics Market Size Growth (2017-2022)
    4.5 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Growth (2017-2022)
5 Americas
    5.1 Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022)
    5.2 Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
    5.3 Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2017-2022)
    6.2 APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
    6.3 APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
    6.4 China
    6.5 Japan
    6.6 Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
7 Europe
    7.1 Europe Healthcare-associated Infectious Disease Diagnostics by Country (2017-2022)
    7.2 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
    7.3 Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics by Region (2017-2022)
    8.2 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022)
    8.3 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022)
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Global Healthcare-associated Infectious Disease Diagnostics Market Forecast
    10.1 Global Healthcare-associated Infectious Disease Diagnostics Forecast by Regions (2023-2028)
        10.1.1 Global Healthcare-associated Infectious Disease Diagnostics Forecast by Regions (2023-2028)
        10.1.2 Americas Healthcare-associated Infectious Disease Diagnostics Forecast
        10.1.3 APAC Healthcare-associated Infectious Disease Diagnostics Forecast
        10.1.4 Europe Healthcare-associated Infectious Disease Diagnostics Forecast
        10.1.5 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Forecast
    10.2 Americas Healthcare-associated Infectious Disease Diagnostics Forecast by Country (2023-2028)
        10.2.1 United States Healthcare-associated Infectious Disease Diagnostics Market Forecast
        10.2.2 Canada Healthcare-associated Infectious Disease Diagnostics Market Forecast
        10.2.3 Mexico Healthcare-associated Infectious Disease Diagnostics Market Forecast
        10.2.4 Brazil Healthcare-associated Infectious Disease Diagnostics Market Forecast
    10.3 APAC Healthcare-associated Infectious Disease Diagnostics Forecast by Region (2023-2028)
        10.3.1 China Healthcare-associated Infectious Disease Diagnostics Market Forecast
        10.3.2 Japan Healthcare-associated Infectious Disease Diagnostics Market Forecast
        10.3.3 Korea Healthcare-associated Infectious Disease Diagnostics Market Forecast
        10.3.4 Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Forecast
        10.3.5 India Healthcare-associated Infectious Disease Diagnostics Market Forecast
        10.3.6 Australia Healthcare-associated Infectious Disease Diagnostics Market Forecast
    10.4 Europe Healthcare-associated Infectious Disease Diagnostics Forecast by Country (2023-2028)
        10.4.1 Germany Healthcare-associated Infectious Disease Diagnostics Market Forecast
        10.4.2 France Healthcare-associated Infectious Disease Diagnostics Market Forecast
        10.4.3 UK Healthcare-associated Infectious Disease Diagnostics Market Forecast
        10.4.4 Italy Healthcare-associated Infectious Disease Diagnostics Market Forecast
        10.4.5 Russia Healthcare-associated Infectious Disease Diagnostics Market Forecast
    10.5 Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Forecast by Region (2023-2028)
        10.5.1 Egypt Healthcare-associated Infectious Disease Diagnostics Market Forecast
        10.5.2 South Africa Healthcare-associated Infectious Disease Diagnostics Market Forecast
        10.5.3 Israel Healthcare-associated Infectious Disease Diagnostics Market Forecast
        10.5.4 Turkey Healthcare-associated Infectious Disease Diagnostics Market Forecast
        10.5.5 GCC Countries Healthcare-associated Infectious Disease Diagnostics Market Forecast
    10.6 Global Healthcare-associated Infectious Disease Diagnostics Forecast by Type (2023-2028)
    10.7 Global Healthcare-associated Infectious Disease Diagnostics Forecast by Application (2023-2028)

11 Key Players Analysis
    11.1 Abbott
        11.1.1 Abbott Company Information
        11.1.2 Abbott Healthcare-associated Infectious Disease Diagnostics Product Offered
        11.1.3 Abbott Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.1.4 Abbott Main Business Overview
        11.1.5 Abbott Latest Developments
    11.2 Accelerate Diagnostics
        11.2.1 Accelerate Diagnostics Company Information
        11.2.2 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product Offered
        11.2.3 Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.2.4 Accelerate Diagnostics Main Business Overview
        11.2.5 Accelerate Diagnostics Latest Developments
    11.3 BD
        11.3.1 BD Company Information
        11.3.2 BD Healthcare-associated Infectious Disease Diagnostics Product Offered
        11.3.3 BD Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.3.4 BD Main Business Overview
        11.3.5 BD Latest Developments
    11.4 bioMrieux
        11.4.1 bioMrieux Company Information
        11.4.2 bioMrieux Healthcare-associated Infectious Disease Diagnostics Product Offered
        11.4.3 bioMrieux Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.4.4 bioMrieux Main Business Overview
        11.4.5 bioMrieux Latest Developments
    11.5 Bio-Rad
        11.5.1 Bio-Rad Company Information
        11.5.2 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product Offered
        11.5.3 Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.5.4 Bio-Rad Main Business Overview
        11.5.5 Bio-Rad Latest Developments
    11.6 DiaSorin Molecular
        11.6.1 DiaSorin Molecular Company Information
        11.6.2 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product Offered
        11.6.3 DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.6.4 DiaSorin Molecular Main Business Overview
        11.6.5 DiaSorin Molecular Latest Developments
    11.7 F. Hoffmann-La Roche
        11.7.1 F. Hoffmann-La Roche Company Information
        11.7.2 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product Offered
        11.7.3 F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.7.4 F. Hoffmann-La Roche Main Business Overview
        11.7.5 F. Hoffmann-La Roche Latest Developments
    11.8 Luminex
        11.8.1 Luminex Company Information
        11.8.2 Luminex Healthcare-associated Infectious Disease Diagnostics Product Offered
        11.8.3 Luminex Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.8.4 Luminex Main Business Overview
        11.8.5 Luminex Latest Developments
    11.9 Meridian Bioscience
        11.9.1 Meridian Bioscience Company Information
        11.9.2 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product Offered
        11.9.3 Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.9.4 Meridian Bioscience Main Business Overview
        11.9.5 Meridian Bioscience Latest Developments
    11.10 OpGen
        11.10.1 OpGen Company Information
        11.10.2 OpGen Healthcare-associated Infectious Disease Diagnostics Product Offered
        11.10.3 OpGen Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.10.4 OpGen Main Business Overview
        11.10.5 OpGen Latest Developments
    11.11 QIAGEN
        11.11.1 QIAGEN Company Information
        11.11.2 QIAGEN Healthcare-associated Infectious Disease Diagnostics Product Offered
        11.11.3 QIAGEN Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.11.4 QIAGEN Main Business Overview
        11.11.5 QIAGEN Latest Developments
    11.12 Quidel
        11.12.1 Quidel Company Information
        11.12.2 Quidel Healthcare-associated Infectious Disease Diagnostics Product Offered
        11.12.3 Quidel Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.12.4 Quidel Main Business Overview
        11.12.5 Quidel Latest Developments
    11.13 Thermo Fisher Scientific
        11.13.1 Thermo Fisher Scientific Company Information
        11.13.2 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product Offered
        11.13.3 Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.13.4 Thermo Fisher Scientific Main Business Overview
        11.13.5 Thermo Fisher Scientific Latest Developments
    11.14 Trinity Biotech
        11.14.1 Trinity Biotech Company Information
        11.14.2 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product Offered
        11.14.3 Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.14.4 Trinity Biotech Main Business Overview
        11.14.5 Trinity Biotech Latest Developments
    11.15 Danaher
        11.15.1 Danaher Company Information
        11.15.2 Danaher Healthcare-associated Infectious Disease Diagnostics Product Offered
        11.15.3 Danaher Healthcare-associated Infectious Disease Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
        11.15.4 Danaher Main Business Overview
        11.15.5 Danaher Latest Developments
12 Research Findings and Conclusion

List of Tables
    Table 1. Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
    Table 2. Major Players of Urinary Tract Infections
    Table 3. Major Players of Surgical Site Infections
    Table 4. Major Players of Hospital-acquired Pneumonia
    Table 5. Major Players of BloodStream Infections
    Table 6. Major Players of Gastrointestinal Infections
    Table 7. Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
    Table 8. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & ($ Millions)
    Table 9. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2022)
    Table 10. Healthcare-associated Infectious Disease Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
    Table 11. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & ($ Millions)
    Table 12. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2022)
    Table 13. Global Healthcare-associated Infectious Disease Diagnostics Revenue by Players (2020-2022) & ($ Millions)
    Table 14. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Player (2020-2022)
    Table 15. Healthcare-associated Infectious Disease Diagnostics Key Players Head office and Products Offered
    Table 16. Healthcare-associated Infectious Disease Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 17. New Products and Potential Entrants
    Table 18. Mergers & Acquisitions, Expansion
    Table 19. Global Healthcare-associated Infectious Disease Diagnostics Market Size by Regions 2017-2022 & ($ Millions)
    Table 20. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Regions (2017-2022)
    Table 21. Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022) & ($ Millions)
    Table 22. Americas Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Country (2017-2022)
    Table 23. Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & ($ Millions)
    Table 24. Americas Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2022)
    Table 25. Americas Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & ($ Millions)
    Table 26. Americas Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2022)
    Table 27. APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2017-2022) & ($ Millions)
    Table 28. APAC Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Region (2017-2022)
    Table 29. APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & ($ Millions)
    Table 30. APAC Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2022)
    Table 31. APAC Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & ($ Millions)
    Table 32. APAC Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2022)
    Table 33. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Country (2017-2022) & ($ Millions)
    Table 34. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Country (2017-2022)
    Table 35. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & ($ Millions)
    Table 36. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2022)
    Table 37. Europe Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & ($ Millions)
    Table 38. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2022)
    Table 39. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Region (2017-2022) & ($ Millions)
    Table 40. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Region (2017-2022)
    Table 41. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Type (2017-2022) & ($ Millions)
    Table 42. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type (2017-2022)
    Table 43. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size by Application (2017-2022) & ($ Millions)
    Table 44. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application (2017-2022)
    Table 45. Key Market Drivers & Growth Opportunities of Healthcare-associated Infectious Disease Diagnostics
    Table 46. Key Market Challenges & Risks of Healthcare-associated Infectious Disease Diagnostics
    Table 47. Key Industry Trends of Healthcare-associated Infectious Disease Diagnostics
    Table 48. Global Healthcare-associated Infectious Disease Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)
    Table 49. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share Forecast by Regions (2023-2028)
    Table 50. Global Healthcare-associated Infectious Disease Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)
    Table 51. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share Forecast by Type (2023-2028)
    Table 52. Global Healthcare-associated Infectious Disease Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)
    Table 53. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share Forecast by Application (2023-2028)
    Table 54. Abbott Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
    Table 55. Abbott Healthcare-associated Infectious Disease Diagnostics Product Offered
    Table 56. Abbott Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 57. Abbott Main Business
    Table 58. Abbott Latest Developments
    Table 59. Accelerate Diagnostics Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
    Table 60. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Product Offered
    Table 61. Accelerate Diagnostics Main Business
    Table 62. Accelerate Diagnostics Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 63. Accelerate Diagnostics Latest Developments
    Table 64. BD Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
    Table 65. BD Healthcare-associated Infectious Disease Diagnostics Product Offered
    Table 66. BD Main Business
    Table 67. BD Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 68. BD Latest Developments
    Table 69. bioMrieux Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
    Table 70. bioMrieux Healthcare-associated Infectious Disease Diagnostics Product Offered
    Table 71. bioMrieux Main Business
    Table 72. bioMrieux Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 73. bioMrieux Latest Developments
    Table 74. Bio-Rad Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
    Table 75. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Product Offered
    Table 76. Bio-Rad Main Business
    Table 77. Bio-Rad Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 78. Bio-Rad Latest Developments
    Table 79. DiaSorin Molecular Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
    Table 80. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Product Offered
    Table 81. DiaSorin Molecular Main Business
    Table 82. DiaSorin Molecular Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 83. DiaSorin Molecular Latest Developments
    Table 84. F. Hoffmann-La Roche Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
    Table 85. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Product Offered
    Table 86. F. Hoffmann-La Roche Main Business
    Table 87. F. Hoffmann-La Roche Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 88. F. Hoffmann-La Roche Latest Developments
    Table 89. Luminex Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
    Table 90. Luminex Healthcare-associated Infectious Disease Diagnostics Product Offered
    Table 91. Luminex Main Business
    Table 92. Luminex Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 93. Luminex Latest Developments
    Table 94. Meridian Bioscience Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
    Table 95. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Product Offered
    Table 96. Meridian Bioscience Main Business
    Table 97. Meridian Bioscience Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 98. Meridian Bioscience Latest Developments
    Table 99. OpGen Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
    Table 100. OpGen Healthcare-associated Infectious Disease Diagnostics Product Offered
    Table 101. OpGen Main Business
    Table 102. OpGen Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 103. OpGen Latest Developments
    Table 104. QIAGEN Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
    Table 105. QIAGEN Healthcare-associated Infectious Disease Diagnostics Product Offered
    Table 106. QIAGEN Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 107. QIAGEN Main Business
    Table 108. QIAGEN Latest Developments
    Table 109. Quidel Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
    Table 110. Quidel Healthcare-associated Infectious Disease Diagnostics Product Offered
    Table 111. Quidel Main Business
    Table 112. Quidel Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 113. Quidel Latest Developments
    Table 114. Thermo Fisher Scientific Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
    Table 115. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Product Offered
    Table 116. Thermo Fisher Scientific Main Business
    Table 117. Thermo Fisher Scientific Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 118. Thermo Fisher Scientific Latest Developments
    Table 119. Trinity Biotech Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
    Table 120. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Product Offered
    Table 121. Trinity Biotech Main Business
    Table 122. Trinity Biotech Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 123. Trinity Biotech Latest Developments
    Table 124. Danaher Details, Company Type, Healthcare-associated Infectious Disease Diagnostics Area Served and Its Competitors
    Table 125. Danaher Healthcare-associated Infectious Disease Diagnostics Product Offered
    Table 126. Danaher Main Business
    Table 127. Danaher Healthcare-associated Infectious Disease Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
    Table 128. Danaher Latest Developments
List of Figures
    Figure 1. Healthcare-associated Infectious Disease Diagnostics Report Years Considered
    Figure 2. Research Objectives
    Figure 3. Research Methodology
    Figure 4. Research Process and Data Source
    Figure 5. Global Healthcare-associated Infectious Disease Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)
    Figure 6. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type in 2021
    Figure 7. Healthcare-associated Infectious Disease Diagnostics in Hospitals
    Figure 8. Global Healthcare-associated Infectious Disease Diagnostics Market: Hospitals (2017-2022) & ($ Millions)
    Figure 9. Healthcare-associated Infectious Disease Diagnostics in Clinics
    Figure 10. Global Healthcare-associated Infectious Disease Diagnostics Market: Clinics (2017-2022) & ($ Millions)
    Figure 11. Healthcare-associated Infectious Disease Diagnostics in ASCs
    Figure 12. Global Healthcare-associated Infectious Disease Diagnostics Market: ASCs (2017-2022) & ($ Millions)
    Figure 13. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application in 2021
    Figure 14. Global Healthcare-associated Infectious Disease Diagnostics Revenue Market Share by Player in 2021
    Figure 15. Global Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Regions (2017-2022)
    Figure 16. Americas Healthcare-associated Infectious Disease Diagnostics Market Size 2017-2022 ($ Millions)
    Figure 17. APAC Healthcare-associated Infectious Disease Diagnostics Market Size 2017-2022 ($ Millions)
    Figure 18. Europe Healthcare-associated Infectious Disease Diagnostics Market Size 2017-2022 ($ Millions)
    Figure 19. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size 2017-2022 ($ Millions)
    Figure 20. Americas Healthcare-associated Infectious Disease Diagnostics Value Market Share by Country in 2021
    Figure 21. Americas Healthcare-associated Infectious Disease Diagnostics Consumption Market Share by Type in 2021
    Figure 22. Americas Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application in 2021
    Figure 23. United States Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 24. Canada Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 25. Mexico Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 26. Brazil Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 27. APAC Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Region in 2021
    Figure 28. APAC Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application in 2021
    Figure 29. China Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 30. Japan Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 31. Korea Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 32. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 33. India Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 34. Australia Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 35. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Country in 2021
    Figure 36. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type in 2021
    Figure 37. Europe Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application in 2021
    Figure 38. Germany Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 39. France Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 40. UK Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 41. Italy Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 42. Russia Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 43. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Region in 2021
    Figure 44. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Type in 2021
    Figure 45. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size Market Share by Application in 2021
    Figure 46. Egypt Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 47. South Africa Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 48. Israel Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 49. Turkey Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 50. GCC Country Healthcare-associated Infectious Disease Diagnostics Market Size Growth 2017-2022 ($ Millions)
    Figure 51. Americas Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 52. APAC Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 53. Europe Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 54. Middle East & Africa Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 55. United States Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 56. Canada Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 57. Mexico Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 58. Brazil Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 59. China Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 60. Japan Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 61. Korea Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 62. Southeast Asia Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 63. India Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 64. Australia Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 65. Germany Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 66. France Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 67. UK Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 68. Italy Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 69. Russia Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 70. Spain Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 71. Egypt Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 72. South Africa Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 73. Israel Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 74. Turkey Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
    Figure 75. GCC Countries Healthcare-associated Infectious Disease Diagnostics Market Size 2023-2028 ($ Millions)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Healthcare-associated Infectious Disease Diagnostics Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Healthcare-associated Infectious Disease Diagnostics Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Healthcare-associated Infectious Disease Diagnostics Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports